Showing results (251-260 of 981) with videos related to

Sort By:
Pageof 99
Cardiovascular Therapeutics|June 1, 2016
Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) miceVrushali Deshpande, Rameshkumar Krishnan, Sheena Philip, et al.
Cardiovascular Therapeutics|May 24, 2016
Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based studyYun Jung Choi, Young-Mi Ah, Jisun Kong, et al.
Cardiovascular Therapeutics|August 12, 2017
Comparison of anticoagulation regimens for pregnant women with prosthetic heart valves: A meta-analysis of prospective studiesJing Wang, Kangqi Li, Hongyan Li, et al.
Cardiovascular Therapeutics|September 12, 2018
Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in ratsKai Zhang, Zuowang Ma, Weiding Wang, et al.
Cardiovascular Therapeutics|March 10, 2017
Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapyStephen Rankin, Douglas H Elder, Simon Ogston, et al.
Cardiovascular Therapeutics|March 16, 2017
Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic ratsOliul Islam, Prashanth Patil, Sumanta K Goswami, et al.
Cardiovascular Therapeutics|May 20, 2008
The novel antioxidant edaravone: from bench to bedsideToshiaki Watanabe, Munenori Tahara, Satoru Todo
Cardiovascular Therapeutics|May 20, 2008
Simvastatin: two decades in a circleGenovefa D Kolovou, Anagnostopoulou Katerina, Vasiliadis Ioannis, et al.
Cardiovascular Therapeutics|May 10, 2008
Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyondNina Kaludercic, Merry L Lindsey, Barbara Tavazzi, et al.
Cardiovascular Therapeutics|May 10, 2008
Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular diseaseSho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, et al.
Pageof 99